The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
HER2-low breast cancer brain metastases: Incidence and treatment implications.
 
Rania Chehade
No Relationships to Disclose
 
Sharon Nofech-Mozes
No Relationships to Disclose
 
Anna Plotkin
No Relationships to Disclose
 
Veronika Moravan
No Relationships to Disclose
 
Katarzyna Joanna Jerzak
Honoraria - Amgen; Apobiologix; AstraZeneca; Eisai; Genomic Health; Gilead Sciences; Knight Therapeutics; Lilly; Merck; Myriad Genetics; Novartis; Pfizer; Roche; Seagen
Consulting or Advisory Role - Amgen; Apobiologix; AstraZeneca; Eisai; Genomic Health; Gilead Sciences; Knight Therapeutics; Lilly; Merck; Myriad Genetics; Novartis; Pfizer; Roche; Seagen; Seagen
Research Funding - AstraZeneca; Lilly; Seagen
Patents, Royalties, Other Intellectual Property - I am the lead inventor on a patent for the use of dronedarone and its structural derivatives as cancer therapies.
Other Relationship - Roche